Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
ONVO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.47%81.210.9%$648.72m
CELGCelgene Corporation
-10.76%121.331.1%$640.82m
AMGNAmgen Inc.
-0.63%182.961.1%$453.41m
BIIBBiogen Inc.
-1.26%338.101.2%$410.25m
REGNRegeneron Pharmaceuticals, Inc.
-1.81%432.982.7%$314.62m
VRTXVertex Pharmaceuticals Incorporated
0.02%154.631.9%$217.79m
INCYIncyte Corporation
-0.07%114.192.5%$202.03m
ALXNAlexion Pharmaceuticals, Inc.
-1.08%138.941.9%$183.38m
ALNYAlnylam Pharmaceuticals, Inc
-0.82%114.6810.7%$157.13m
EXELExelixis, Inc.
-1.06%27.176.5%$135.00m
ILMNIllumina, Inc.
2.29%209.883.5%$132.21m
BLUEBluebird Bio, Inc.
2.22%142.5517.3%$118.24m
BMRNBioMarin Pharmaceutical Inc.
-0.43%87.754.4%$113.37m
SRPTSarepta Therapeutics, Inc.
2.41%51.9416.9%$108.74m
CLVSClovis Oncology, Inc.
0.95%77.5016.5%$103.06m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.